← PUMA BIOTECHNOLOGY, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $194.5m | $81.7m | $108.4m | $60.0m | $85.3m | $63.1m | $76.2m | $84.6m | $69.2m | $29.6m | |
| Prepaid Expense and Other Assets, Current | $7.0m | $13.0m | $12.4m | $13.3m | $11.3m | — | — | — | — | — | |
| Cash, Cash Equivalents, and Short-term Investments | $229.4m | $81.7m | — | — | — | $69.8m | $46.5m | $48.9m | $86.8m | $91.6m | |
| Inventory, Net | — | $2.0m | $2.6m | $3.2m | $3.5m | $7.1m | $4.5m | $7.1m | $8.7m | $5.5m | |
| Accounts Receivable, after Allowance for Credit Loss | — | — | — | $28.9m | $25.5m | $32.5m | — | $47.8m | $32.0m | $53.7m | |
| Assets, Current | $236.5m | $106.4m | $203.0m | $166.3m | $146.1m | $140.0m | $134.3m | $156.2m | $147.7m | $162.7m | |
| Property, Plant and Equipment, Net | $5.2m | $4.5m | $4.0m | $3.3m | $2.5m | $1.8m | $1.1m | $855k | $515k | $187k | |
| Operating Lease, Right-of-Use Asset | — | — | — | $18.5m | $16.4m | $14.0m | $11.4m | $7.8m | $4.6m | $5.4m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | $9.7m | $20.8m | $28.9m | $25.5m | $32.5m | $40.4m | $47.8m | $32.0m | $53.7m | |
| Accrued Liabilities, Current | $17.4m | $30.6m | $46.4m | $69.0m | $61.3m | $92.6m | $53.0m | $52.7m | $36.9m | $50.0m | |
| Assets | $252.8m | $165.5m | $259.1m | $234.9m | $244.2m | $226.6m | $222.1m | $230.5m | $213.3m | $216.3m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $2.6m | $3.1m | $3.6m | $4.1m | $4.8m | $5.5m | $1.3m | |
| Accounts Payable, Current | $20.0m | $27.7m | $20.7m | $19.2m | $12.1m | $11.2m | $6.4m | $6.9m | $5.5m | $5.1m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $22.6m | $19.5m | $16.0m | $11.8m | $7.0m | $1.5m | $4.7m | |
| Long-term Debt, Excluding Current Maturities | — | $48.5m | $151.9m | $95.0m | $84.0m | $97.1m | $98.3m | $65.7m | $21.7m | $0 | |
| Long-term Debt, Current Maturities | — | — | — | — | $14.3m | $0 | — | $34.0m | $45.3m | $22.5m | |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | $84.0m | $97.1m | $98.3m | $65.7m | $21.7m | $0 | |
| Liabilities, Current | $37.5m | $58.3m | $67.1m | $90.8m | $114.3m | $109.6m | $77.5m | $99.4m | $96.1m | $81.3m | |
| Other Liabilities, Noncurrent | — | — | — | — | — | — | — | — | $121k | $0 | |
| Liabilities | $43.0m | $112.2m | $224.8m | $217.4m | $250.2m | $229.0m | $200.5m | $177.1m | $121.2m | $86.0m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $4k | $4k | $4k | $4k | $4k | $4k | $5k | $5k | $5k | $5k | |
| Retained Earnings (Accumulated Deficit) | ($796.5m) | ($1.1b) | ($1.2b) | ($1.3b) | ($1.3b) | ($1.4b) | ($1.4b) | ($1.3b) | ($1.3b) | ($1.3b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($13k) | — | ($12k) | $62k | — | ($2k) | $0 | ($4k) | $6k | $36k | |
| Additional Paid in Capital, Common Stock | $1.0b | $1.1b | $1.2b | $1.3b | $1.3b | $1.4b | $1.4b | $1.4b | $1.4b | $1.4b | |
| Stockholders' Equity Attributable to Parent | $209.8m | $53.3m | $34.3m | $17.5m | ($6.0m) | ($2.4m) | $21.6m | $53.4m | $92.1m | $130.3m | |
| Liabilities and Equity | $252.8m | $165.5m | $259.1m | $234.9m | $244.2m | $226.6m | $222.1m | $230.5m | $213.3m | $216.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.